These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7616740)

  • 1. Clinical development plan: 2-difluoromethylornithine (DFMO).
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():147-65. PubMed ID: 7616740
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical development plan: 18beta-glycyrrhetinic acid.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():166-75. PubMed ID: 7616741
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical development plan: sulindac.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():240-51. PubMed ID: 7616747
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical development plan: piroxicam.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():219-30. PubMed ID: 7616745
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical development plan: N-Acetyl-l-cysteine.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():63-73. PubMed ID: 7616754
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical development plan: tamoxifen.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():252-67. PubMed ID: 7616749
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical development plan: vitamin D3 and analogs.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():268-81. PubMed ID: 7616750
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical development plan: vitamin E.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():282-99. PubMed ID: 7616751
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical development plan: N-(4-hydroxyphenyl)retinamide.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():176-96. PubMed ID: 7616742
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical development plan: DHEA analog 8354.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():141-6. PubMed ID: 7616739
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical development plan: oltipraz.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():205-18. PubMed ID: 7616744
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical development plan: calcium.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():86-109. PubMed ID: 7616756
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical development plan: Proscar.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():231-9. PubMed ID: 7616746
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
    Meyskens FL; Gerner EW
    Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical development plan: beta-carotene and other carotenoids.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():110-140. PubMed ID: 7616738
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical development plan: ibuprofen.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():197-204. PubMed ID: 7616743
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical development plan: 13-cis-retinoic acid.
    J Cell Biochem Suppl; 1996; 26():168-201. PubMed ID: 9154177
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical development plan: aspirin.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():74-85. PubMed ID: 7616755
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary and erythrocyte polyamines during the evaluation of oral alpha-difluoromethylornithine in a phase I chemoprevention clinical trial.
    Pendyala L; Creaven PJ; Porter CW
    Cancer Epidemiol Biomarkers Prev; 1993; 2(3):235-41. PubMed ID: 8318876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss.
    Wheeler DL; Ness KJ; Oberley TD; Verma AK
    Cancer Res; 2003 Jun; 63(12):3037-42. PubMed ID: 12810623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.